Status:
RECRUITING
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
Lead Sponsor:
The Cooper Health System
Collaborating Sponsors:
University of California, Davis
Washington University School of Medicine
Conditions:
Surgical Wound Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to learn if reducing bacterial load on the skin and nostrils with topical antibacterial soap and ointment, respectively, reduces rate of infection in surgical sites ...
Detailed Description
The goal of this clinical trial is to learn if reducing bacterial load on the skin and nostrils with topical antibacterial soap and ointment, respectively, reduces rate of infection in surgical sites ...
Eligibility Criteria
Inclusion
- Age at least 18 years old
- Scheduled to undergo surgical treatment for skin cancer on the lower extremities and have no other surgeries scheduled in the coming weeks after the procedure
- Will have a surgical wound that will be left open to heal by secondary intention
Exclusion
- Age under 18 years old
- Have a known allergy to chlorhexidine or mupirocin
- Have a history of Staphylococcus aureus infection
- Have a history of heart valve or joint replacement surgery requiring pre-operative antibiotics
Key Trial Info
Start Date :
March 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
848 Patients enrolled
Trial Details
Trial ID
NCT07142408
Start Date
March 13 2023
End Date
December 1 2030
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Center for Dermatologic Surgery at Cooper University Health Care
Marlton, New Jersey, United States, 08053